Long-term Efficacy of Raltegravir or Efavirenz Combined with TDF/FTC in Treatment-naïve HIV-1-infected Patients: Week-192 Subgroup Analyses from STARTMRK
Reported by Jules Levin
EACS - European AIDS Conference Oct 12-15 2011 Belgrade, Serbia
J. K. Rockstroh, A. Lazzarin, J. Zhao, A. Rodgers, M. J. DiNubile, B-Y. Nguyen,
R. Leavitt, H. Teppler, and P. Sklar for the STARTMRK Study Team
